MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mpa.0000000000002443

Медицинская библиотека · Pancreas · 2025

Circulating Biomarkers of Macrophage Activation in Different Stages of Chronic Pancreatitis: A Pilot Study.

Hagn-Meincke Rasmus, Novovic Srdan, Hadi Amer, Jensen Annette B, Drewes Asbjørn M, Krarup Henrik, Frøkjær Jens B, Park Walter G, Jørgensen Peter L, Møller Holger Jon, Deleuran Bent W, Olesen Søren S

СтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

OBJECTIVES

Activation of type M2 macrophages has been implicated in the pathogenesis of chronic pancreatitis (CP). In a clinical pilot study, we investigated blood-based markers of macrophage activation at different stages of CP.

MATERIALS AND

METHODS

We performed a cross-sectional analysis of prospectively collected plasma samples from healthy controls and patients with suspected or definitive CP according to the M-ANNHEIM criteria. Plasma concentrations of soluble CD163 (sCD163), soluble CD206 (sCD206), and monocyte chemoattractant protein-1 (MCP-1) were analyzed using enzyme-linked immunosorbent assays. Group and pairwise comparisons of analytes were performed using regression models and area under the receiver operating curves (AUC-ROC).

RESULTS

In total, 73 subjects with CP (28 suspected CP and 45 definitive CP) and 40 controls were included. Compared to controls, the median plasma concentrations of sCD163 ( P  = 0.019) and sCD206 ( P  = 0.033) were elevated in patients with definitive CP. sCD206 was also elevated in patients with definitive CP ( P  = 0.042) compared to suspected CP. ROC analysis revealed the optimal sCD163 cutpoint to distinguish definitive CP from controls was 1.84 mg/mL (AUC-ROC 0.65; 95% confidence interval [CI], 0.54-0.77). The optimal sCD206 cutpoint to distinguish definitive CP from controls was 0.24 mg/mL (AUC-ROC 0.66; 95% CI, 0.54-0.78). MCP-1 concentrations showed no differences across subgroups.

CONCLUSION

Our study demonstrates that subjects with definitive CP, sampled during a clinically quiescent phase, exhibited increased levels of sCD163 and sCD206. This indicates the presence of activated M2 macrophages in patients with CP at advanced, but not early, clinical stages.

Для цитирования: Hagn-Meincke Rasmus, Novovic Srdan, Hadi Amer, Jensen Annette B, Drewes Asbjørn M, Krarup Henrik, Frøkjær Jens B, Park Walter G, Jørgensen Peter L, Møller Holger Jon, Deleuran Bent W, Olesen Søren S. Circulating Biomarkers of Macrophage Activation in Different Stages of Chronic Pancreatitis: A Pilot Study.. Pancreas. 2025. DOI: 10.1097/mpa.0000000000002443.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.